Published in J Cancer on January 12, 2016
Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget (2016) 0.89
The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature. J Cancer (2016) 0.88
High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma. J Cancer (2017) 0.79
Circular RNAs in human cancer. Mol Cancer (2017) 0.78
Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer. J Cancer (2016) 0.77
Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. Oncotarget (2017) 0.76
Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer. J Cancer (2017) 0.75
Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. J Cancer (2017) 0.75
The NOR1/OSCP1 proteins in cancer: from epigenetic silencing to functional characterization of a novel tumor suppressor. J Cancer (2017) 0.75
Role of tumor microenvironment in tumorigenesis. J Cancer (2017) 0.75
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy. Oncotarget (2017) 0.75
Retrospective Proteomic Screening of 100 Breast Cancer Tissues. Proteomes (2017) 0.75
Nasopharyngeal carcinoma. Lancet (2005) 7.16
The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61
A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res (2004) 1.65
Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res (2010) 1.46
Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int J Biochem Cell Biol (2004) 1.40
Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res (2008) 1.33
The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta (2011) 1.32
Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol (2000) 1.15
Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. Biochem Soc Trans (2011) 1.10
Staging of nasopharyngeal carcinoma--the past, the present and the future. Oral Oncol (2013) 1.09
Significant overexpression of Hsp110 gene during colorectal cancer progression. Oncol Rep (2009) 1.09
LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene (2013) 1.04
Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med (2006) 1.03
Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer (2003) 0.99
Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts. Histochem Cell Biol (2010) 0.94
HYOU1/Orp150 expression in breast cancer. Med Sci Monit (2007) 0.93
Up-regulation of 150-kDa oxygen-regulated protein by celecoxib in human gastric carcinoma cells. Mol Pharmacol (2006) 0.93
14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Mol Cancer Ther (2006) 0.92
Molecular chaperone ORP150 in ER stress-related diseases. Curr Pharm Des (2013) 0.89
Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells. Int J Urol (2002) 0.88
LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One (2013) 0.86
A Review: Proteomics in Nasopharyngeal Carcinoma. Int J Mol Sci (2015) 0.84
Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. BJU Int (2002) 0.83
Analysis of the contribution of nasopharyngeal epithelial cancer cells to the induction of a local inflammatory response. J Cancer Res Clin Oncol (2011) 0.83
Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma. Mol Med Rep (2014) 0.82
The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiation. Int J Mol Sci (2012) 0.82
Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis. Eur J Cancer Prev (2013) 0.82
Targeted proteomic analysis of 14-3-3sigma in nasopharyngeal carcinoma. Int J Biochem Cell Biol (2009) 0.81
Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses (2013) 0.81
Implication of oxygen-regulated protein 150 (ORP150) in apoptosis induced by proteasome inhibitors in human thyroid cancer cells. J Clin Endocrinol Metab (2010) 0.81
Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clin Proteomics (2015) 0.80
Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells. Chin Med J (Engl) (2008) 0.80
Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer. J Cancer (2015) 0.80
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients. Emerg Microbes Infect (2015) 0.78
Annexin A1 in malignant tumors: current opinions and controversies. Int J Biol Markers (2014) 0.77